| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.44 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.003 |